Production Linked Incentive (PLI) scheme for the Pharmaceutical Sector

Part of: GS Prelims and GS- III – Economy; Manufacturing sector 

In News: The PLI Scheme for Pharmaceuticals is based on the strategy of “Atmanirbhar Bharat- Strategies for enhancing India’s manufacturing capabilities and enhancing exports in ten sectors”, which had been approved by the Union Cabinet.

Objectives 

About the Scheme

The Scheme is expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector.

    1. Category 1: Biopharmaceuticals; Complex generic drugs; Patented drugs or drugs nearing patent expiry; Cell-based or gene therapy drugs; Orphan drugs; Other drugs as approved.
    2. Category 2: Active Pharmaceutical Ingredients, Key Starting Materials, Drug Intermediates.
    3. Category 3: Drugs not covered under Category 1 and 2.

News Source: PIB

Search now.....

Sign Up To Receive Regular Updates